Clin2
NCT07439042Possibly a fitNot yet recruiting

Buspirone for anxiety in children with autism

AnxietyAutism Spectrum Disorder

Treatments studied

Part of Mental health clinical trials.

This trial tests whether buspirone, a medication that helps with anxiety, can reduce anxiety in children and teens with autism. It is a 12-week study where participants receive buspirone or a placebo (a pill with no medicine) to see if it improves anxiety symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
20 people
Ages
7 years to 17 years
Study type
Interventional

Who can take part

  • Your child is between 7 and 17 years old.
  • Your child has a confirmed autism diagnosis.
  • Your child has at least moderate social anxiety, separation anxiety, or generalized anxiety.
  • Your child is not on certain anxiety or mood medications (like SSRIs, benzodiazepines) and has never tried buspirone before.
  • Your child can swallow capsules or take a liquid medication.
  • Your child does not have a genetic syndrome, heart rhythm problem, or certain other psychiatric diagnoses.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06526208Recruiting· Phase 2
Marijuana-based compound for anxiety in autistic adults

This study tests a marijuana-based compound (similar to CBD but not psychoactive) to see if it helps reduce anxiety in autistic adults. You would take a daily capsule and be monitored for 12 weeks.

Phoenix, Arizona
NCT05501678Recruiting· Phase 2
Diphenhydramine to help sleep in autistic children

This Phase 2 study tests whether diphenhydramine improves sleep in children with autism who have significant sleep problems. It requires sleep monitoring (watch data and sleep testing) and checking for side effects to see if the treatment is safe and helpful.

Stanford, California
NCT06081348Recruiting· Phase 2
Sertraline vs. placebo for anxiety in kids with developmental disorders

This trial compares sertraline (a common antidepressant) to a placebo (a pill with no medicine) to see which better reduces anxiety in children and teens who also have a neurodevelopmental disorder like autism, ADHD, or Tourette's. The goal is to help you and your child understand if this treatment might offer relief from anxiety.

Calgary, Alberta
NCT06826326Enrolling by invitation· Phase 2
Brain imaging of an antidepressant in teens with autism

This study tests if the antidepressant escitalopram can improve brain function in teenagers with autism. Participants will take the medicine and have brain scans (MRI) to see how it affects brain activity.

Kansas City, Kansas
NCT03866668Recruiting· Phase 2
Esomeprazole for young children with autism

This Phase 2 study tests whether esomeprazole helps children with autism. It looks at children who are generally healthy, take stable medicines, and can reliably attend visits so their care team can track changes during the study.

Stanford, California
NCT05999240Recruiting· Phase 2
Pimavanserin for rigid-compulsive symptoms in autism

This trial tests if the drug pimavanserin can help reduce rigid or repetitive behaviors in people with autism spectrum disorder. It may be an option if you or your child struggle with these symptoms and want to try a new treatment.

Lawrence, Kansas

Hear when a new Anxiety trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.